Parkinsons disease

Isra

Definition

  • Parkinson’s disease is a progressive neurodegenerative disorder due to loss of dopaminergic neurons in the substantia nigra pars compacta, leading to dopamine deficiency in the basal ganglia

Pathophysiology

manifestations appears when 70% of neuron is dead

  • Loss of dopaminergic neurons in substantia nigra pars compacta
  • Lewy bodies (α-synuclein aggregates) (inclusion body) not pathognomonic
  • Imbalance of dopamine vs acetylcholine → motor symptoms → stimulatory neurotransmitter
  • Multifactorial: genetic, oxidative stress, toxins, DM Smoking, CO

dead neuron under microscope

Clinical Features

Motor Symptoms (TRAP) in one side (asymmetrical)

  • Tremor (resting, pill-rolling) from side → most common + Rigid → the: cholinergic antagonist
  • Rigidity (cogwheel/lead pipe) due to loss of dopamine → slow
  • Akinesia/bradykinesia → start monotonous speech / micrographia
  • Postural instability (usually late feature) slow pitch
  • gait (narrowed, shuffling)

Non-Motor Symptoms

  • Depression, anxiety
  • Autonomic: constipation, urinary frequency, orthostatic hypotension
  • Cognitive decline → Parkinson’s dementia → late feature
  • Sleep disorders (REM behavior disorder)
  • Hyposmia (early) Anosmia/

Differential Diagnosis of Parkinson’s Disease

1. Other Parkinsonian Syndromes

  • Drug-induced parkinsonism: Caused by antipsychotics (haloperidol, risperidone) or antiemetics (metoclopramide). Features: symmetric, no resting tremor, improves after stopping drug.
  • Vascular parkinsonism: Due to multiple small strokes. Features:, gait disturbance > tremor, hyperreflexia and poor levodopa response.
  • Normal Pressure Hydrocephalus (NPH): Triad of gait disturbance, urinary incontinence, and dementia. Imaging shows enlarged ventricles with normal pressure.
  • Essential tremor: Action/postural tremor (not resting), improves with alcohol, no rigidity or bradykinesia.

2. Parkinson-Plus Syndromes (Atypical Parkinsonism)

  • Multiple System Atrophy (MSA): Parkinsonism + autonomic failure + cerebellar signs.
  • Progressive Supranuclear Palsy (PSP): Early falls, vertical gaze palsy, axial rigidity.
  • Corticobasal Degeneration (CBD): Asymmetric rigidity, apraxia, alien limb, cortical sensory loss.
  • Dementia with Lewy Bodies (DLB): Early dementia, visual hallucinations, fluctuating cognition, parkinsonism

1. Apraxia

Definition: Inability to perform a learned purposeful movement despite:

  • Intact intellect
  • Normal strength
  • Normal sensation
  • Normal coordination
  • Patient understands the command

2. Alien limb syndrome

Definition: A limb (usually the hand) moves on its own, without the patient’s control.

3. Other Neurological Disorders

  • Wilson’s disease: Young onset, psychiatric symptoms, liver disease, Kayser–Fleischer rings.
  • Huntington’s disease: Chorea, behavioral changes, family history.
  • Post-encephalitic parkinsonism: Rare, history of encephalitis

Red flags against idiopathic Parkinson’s disease

  • Poor or no response to levodopa
  • Early postural instability or falls
  • Rapid progression
  • Early autonomic failure or dementia
  • Symmetrical onset

Investigations

  • Clinical diagnosis (UK Brain Bank criteria)
  • MRI: usually normal, used to exclude other causes “Stroke, NPH”
  • DAT-SPECT: ↓ striatal dopamine uptake

TJBR

  • T → tremor (resting)
  • S → dyskinesia
  • B → Bradykinesia
  • R → Rigidity (lead pipe, cogwheel)
  • Writing (micrographia)
  • Reading (monotonous speech)

Tremor causing drugs → β agonist, Lithium (so, ask in hx)

Pharmacological Management

1. Levodopa + Carbidopa

  • Mechanism: Levodopa is a precursor of dopamine, crosses BBB → converted to dopamine. Carbidopa inhibits peripheral DOPA decarboxylase → ↑ central dopamine.
  • Example: Sinemet®
  • Side effects: [Nausea, vomiting, orthostatic hypotension, Arrhythmias], if ↑ dopa in periphery (centrally) dyskinesias, on-off fluctuations, [hallucinations, Schizophrenic like sx) if ↑ dopa centrally

due to down regulation of receptors

2. Dopamine Agonists

  • Mechanism: Direct stimulation of dopamine receptors (D2 > D3).
  • Examples: Pramipexole, Ropinirole.
  • Side effects: Nausea, hypotension, hallucinations, impulse control disorders (gambling, hypersexuality), sleep attacks.

Used when end of dose phenomena occur

= end of dose phenomena

hypertension (↑ dopamine peripherally will enter neuron → nore epinephrine will go out & work on α receptor)

in other Action potential → dopamine will be released → hypotension

3. MAO-B Inhibitors

  • Mechanism: Inhibit monoamine oxidase-B → ↓ dopamine breakdown in CNS.

  • Examples: Selegiline, Rasagiline

  • Side effects: Insomnia, hypertension (rare), nausea, vomiting

  • MAO B → breaks down dopamine

  • MAO A → breaks down serotonin & NE

4. COMT Inhibitors

  • Mechanism: Inhibit COMT → prolong Levodopa half-life.
  • Examples: Entacapone, Tolcapone.
  • Side effects: Diarrhea, orange urine, hepatotoxicity (Tolcapone)., hallucination

in ↑ MAO B inhibitor MAO A will be affected too (less selectivity loss) → ↑ NE + serotonin → HTN → insomnia

  • COMT enzi → in periphery: convert Levodopa into 3-O-methyl dopa (not cross BBB)
  • Centrally: breaks down dopa
  • So, once inhibited → more dopa enter the brain

5. Amantadine

  • Mechanism: Enhances dopamine release, inhibits reuptake; NMDA receptor antagonist → inhibit glycolated glutamate receptor
  • Example: Amantadine (Symmetrel®).
  • Side effects: Livedo reticularis, edema, confusion, hallucinations.

6. Anticholinergics

  • Mechanism: Block muscarinic receptors → restore balance between dopamine & acetylcholine. Control tremor more

  • Examples: Trihexyphenidyl, Benztropine.

  • Side effects: Dry mouth, blurred vision, urinary retention, constipation, confusion (avoid in elderly).

  • Antiviral

  • → no Ca2+ will enter → no death of neuron

  • DDx:

    • Physiological in newborn
    • APA
    • Surgeon complaining of tremors
    • Dry sandy eyes, mydriasis, tachycardia

عصب و عيار

Good luck

End of dose phenomena treated by SAP

  • S → Selegiline → MAO B inhibitor
  • A → Apomorphine
  • R → Ropinirole
  • Dopamine agonist

Post drug → hx

Post stroke → hx

Pyramidal post stroke → hyperreflexia, plantar drift

Parkinson plus syn

  • multiple system Atrophy (big danger) → BP, horizontal nystagmus
  • progressive Supranuclear palsy → Bilateral disease, poor response to levodopa, young, vertical nystagmus
  • Corticobasal degeneration → glabellar tap, loss of cortical sensation
  • Lewy body dementia → visual hallucination, fluctuating cognition, early dementia

others:

  • Wilson → Kayser Fleischer ring, jaundice
  • Huntington → FR, early with new generation, AD
  • Essential tremor → action tremor, voice tremor, improves with alcohol, treated by BB blocker